/PRNewswire/ The Janssen Pharmaceutical Companies of Johnson & Johnson today announced plans to present more than 20 abstracts featuring seven oncology.
Janssen Data at ASCO GU Support Ambition to Transform Treatment of Prostate and Bladder Cancer Through Precision Medicine and Early Intervention streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
“Most Q&As are happening on Twitter. If you’re not doing social listening you’re losing fresh insights into things like disease states." That was just one of the observations in a new report on how pharma and other life science companies are working with healthcare providers and adapting to improve the patient experience.
Luca Dezzani
Luca Dezzani, MD is a medical doctor with extensive healthcare experience as a physician in clinical practice and in the pharmaceutical industry. He practiced as a physician in Hematology and Internal Medicine before joining Novartis Oncology where he served in roles at national, regional, and global levels in Europe and North America. More recently, he built and led the US Oncology medical organization at Eisai. He has a strong expertise in oncology clinical development and medical affairs, and he is passionate about the application of technology to healthcare. Luca now leads the Immuno-Oncology Franchise within the US Oncology Organization at AstraZeneca.